Napabucasin

Napabucasin

SCHEMBL3654300

CC(=O)c1cc2c(o1)C(=O)c1cc(F)ccc1C2=O.CC(=O)c1cc2c(o1)C(=O)c1ccccc1C2=O

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 6/20 0.78
ALDH1A1 P00352 4/20 0.78
MAPT P10636 6/20 0.43
LMNA P02545 2/20 0.43
HTT P42858 2/20 0.43
MITF O75030 1/20 0.43
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
MEN1 O00255 1/20 0.42
MAOA P21397 1/20 0.42
KMT2A Q03164 1/20 0.42
S100A4 P26447 1/20 0.41
MAPK1 P28482 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TTR P02766 1/20 0.40
ELANE P08246 1/20 0.39
KDM4E B2RXH2 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29364953 0.96 STAT3 (0.69) STAT3ALDH1A1MAPTLMNAHTT
SCHEMBL1881893 0.96 STAT3 (0.69) STAT3ALDH1A1MAPTLMNAHTT
Napabucasin SCHEMBL29349770 0.88 STAT3 (1.00) STAT3ALDH1A1MAPTLMNAHTT
Napabucasin SCHEMBL1883845 0.88 STAT3 (1.00) STAT3ALDH1A1MAPTLMNAHTT
SCHEMBL12640066 0.84 ALDH1A1 (0.54) STAT3ALDH1A1MAPTLMNAHTT
SCHEMBL13925109 0.83 STAT3 (0.52) STAT3ALDH1A1MAPTLMNAHTT
SCHEMBL29364489 0.80 STAT3 (0.71) STAT3ALDH1A1MAPTLMNAHTT
SCHEMBL29362059 0.80 STAT3 (0.71) STAT3ALDH1A1MAPTLMNAHTT
SCHEMBL14656586 0.80 STAT3 (0.71) STAT3ALDH1A1MAPTLMNAHTT
SCHEMBL14656628 0.80 STAT3 (0.71) STAT3ALDH1A1MAPTLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2190429-A1 A NOVEL GROUP OF STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL PATHWAY INHIBITORS Boston Biomedical, Inc. (US) 2010-06-02 EP claimed
WO-2009036099-A1 A NOVEL GROUP OF STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL PATHWAY INHIBITORS BOSTON BIOMEDICAL, INC. (US) 2009-03-19 WO claimed